nicardipine has been researched along with Cognition Disorders in 3 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The lipid-soluble calcium channel-blocking drug nicardipine or matching placebo were randomly assigned to 26 patients with major depressive disorder receiving ECT." | 5.09 | Nicardipine improves the antidepressant action of ECT but does not improve cognition. ( Buzan, R; Cullum, CM; Dubovsky, SL; Kassner, C; Thomas, M, 2001) |
| "Nicardipine is a dihydropyridine-type Ca(2+) channel blocker (CCB) with strong antihypertensive activity and with a peculiar cerebrovascular profile." | 2.45 | Nicardipine use in cerebrovascular disease: a review of controlled clinical studies. ( Amenta, F; Lanari, A; Mignini, F; Silvestrelli, G; Tomassoni, D; Traini, E, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amenta, F | 1 |
| Lanari, A | 1 |
| Mignini, F | 1 |
| Silvestrelli, G | 1 |
| Traini, E | 1 |
| Tomassoni, D | 1 |
| Ikegaya, Y | 1 |
| Nishiyama, N | 1 |
| Matsuki, N | 1 |
| Dubovsky, SL | 1 |
| Buzan, R | 1 |
| Thomas, M | 1 |
| Kassner, C | 1 |
| Cullum, CM | 1 |
1 review available for nicardipine and Cognition Disorders
| Article | Year |
|---|---|
Nicardipine use in cerebrovascular disease: a review of controlled clinical studies.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Cerebrovascular Disorders; Cognition; Cognition D | 2009 |
1 trial available for nicardipine and Cognition Disorders
| Article | Year |
|---|---|
Nicardipine improves the antidepressant action of ECT but does not improve cognition.
Topics: Adult; Age Factors; Calcium Channel Blockers; Cognition Disorders; Depressive Disorder; Double-Blind | 2001 |
1 other study available for nicardipine and Cognition Disorders
| Article | Year |
|---|---|
L-type Ca(2+) channel blocker inhibits mossy fiber sprouting and cognitive deficits following pilocarpine seizures in immature mice.
Topics: Animals; Animals, Newborn; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Cogn | 2000 |